PharmaShots | Incisive News in 3 Shots

Subscribe Now

Vyluma

Vyluma Entered into an Exclusive License Agreement with Théa for the Registration and Commercialization of NVK002 to Treat Myopia

Vyluma Entered into an Exclusive License Agreement with Théa for the Registration and Commercialization of NVK002 to Treat Myopia

June 15, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us